REFERENCES
- Al-Kandari F. H., Ycoub K., Omu F. Initiation factors for substance abuse. J. Adv. Nurs. 2001; 34(1)78–85, [PUBMED], [INFOTRIEVE], [CSA]
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4TH ed. American Psychiatric Association, Washington, DC 1994
- Baeza G. M. Abuso de anticolinérgicos: Contribución a su clínica, Anticholinergic drug abuse: A Clinical contribution. Rev. Psiquiatr 1993; 3: 5–12
- Biernacki P., Waldorf D. Snowball sampling–problems and techniques of chain referral sampling. Sociol Methods Res 1981; 10: 141–163, [CSA]
- BOLIN R. R. Psychiatric manifestations of Artane Toxicity. J Nerv Ment Dis 1960; 131: 256–259
- Braga D., Oliveira Filho J. P., Souza D. C. Nova toxicomania, A new toxicomania. Rev Bras Psiquiatr 1972; 6(1)19–21
- Bryman A., Burgess R. G. Analyzing qualitative data. Routledge, London 1999
- Carlini E. A. Trihexyphenidyl (ArtaneˆledR) and chemical slave labour in Brazil (and abuse of other anthicholinergic drugs): News and Notes. Addiction 1994; 89(3)363
- Carlini E. A., Galduróz J. C. F., Noto A. R., Nappo S. A. I Levantamento Domiciliar Sobre o Uso de Drogas Psicotrópicas no Brasil, First National Domiciliar Survey on drug use in Brazil. Centro Brasileiro de Informações Sobre Drogas Psicotrópicas-Departamento de Psicobiologia—Universidade Federal de São Paulo (UNIFESP), CEBRID, São Paulo 2002
- Creswell J. W. Qualitative Inquiry and Research Design: Choosing Among Five Traditions. Sage Publications, USA 1998
- Guthrie S. K., Manzey L., Scott D., Giordani B., Tandon R. Comparison of central and peripheral pharmacologic effects of biperiden and trihexyphenidyl in human volunteers. J. Clin. Psychopharmacol. 2000; 20(1)77–83, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Kulik A. V., Wilbur R. Delirium and stereotypy from anticholinergic antiparkinson drugs. Prog Neuropsychopharmacol Biol Psychiatry 1982; 6: 75–82, [PUBMED], [INFOTRIEVE]
- Lima J. F. S. Envenenamento de duas pessoas pela trombeteira. [Poisoning of two persons by Datura sp]. J. Gazeta Médica da Bahia 1866; 1: 67–68
- Marken P A., Stoner S C., Bunker M T. Anticholinergic drug abuse and misuse: Epidemiology and therapeutic implications. CNS Drugs 1996; 5(3)190–199
- McInnis M., Peturson H. Withdrawal of trihexyphenidyl. Acta Psychiatr. Scand 1985; 71: 297–303, [PUBMED], [INFOTRIEVE]
- Nappo S. A., Galduróz J. C. F., Noto A. R. Crack use in São Paulo. Subst. Use. Misuse. 1996; 31(5)565–579, [PUBMED], [INFOTRIEVE], [CSA]
- Oliveira A. A., Evans M. Chronic anticholinergic administration: Dependence, withdrawal syndrome, and treatment. Curr. Ther. Res. Clin. Exp. 1988; 44(2)325–328
- Patton M. Q. Qualitative Evaluation and Research Methods. Sage Publications, London 1990
- Sanchez Z. M., Nappo S. A. Progression on drug use and its intervening factors among crack users. Rev. Saude. Publica. 2002; 36(4)420–430
- Siegel R. K. New patterns of cocaine use: changing doses and routes. Cocaine Use in America: Epidemiologic and Clinical Perspective, N. Kozel, E. H. Adams. Rockville, NIDAUSA 1985
- Swadi H. S. Adolescent drug taking: role of family and peers. Drug. Alcohol. Depend 1988; 21(2)157–160, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- WHO. World Health Organization Qualitative Research for Health Programmes. Division of Mental Health Geneva. 1994; 1–102